Bristol-Myers Squibb Co
Stocks making the biggest moves premarket: Meta, Teladoc, Harley-Davidson, Southwest Airlines and more
Harley-Davidson motorcycles are displayed for sale at the Cowboy Harley-Davidson dealership on February 02, 2023 in Austin, Texas. Brandon Bell | Getty Images Check out the companies making headlines before the bell: Meta Platforms – Shares jumped 12% after the Facebook parent surpassed Wall Street’s expectations on the top and bottom lines and issued optimistic […]
Read More
Enjoy protection with these fortress shares in the next quarter
Traders should assume extra volatility as the next quarter gets underway — and they may possibly want to start planning for a recession, experts say. That usually means finding fortress stocks to protect their portfolios. Turmoil in the financial institution sector has renewed fears of an economic slowdown as money institutions tighten lending situations. DoubleLine […]
Read More
Analysts appreciate these stocks that are flush with dollars — giving one more than 75% upside
Investors are planning for a gloomy 2023 by doubling down on funds-abundant companies . “We choose businesses building funds alternatively than those that have to have capital to improve. Not only are costs most likely to stay bigger than they have been in current past, but we are probably exiting an period of hyper-accommodative monetary […]
Read More
Biden administration will select first 10 drugs for Medicare price negotiations by September
The Health and Human Services Department plans to publish in September a list of 10 drugs covered by Medicare that it will target for price negotiations, the first phase in a long awaited effort to cut costs for seniors. HHS officials, in a call with reporters on Wednesday, laid out the federal government’s road map […]
Read More
What to watch for as J&J gets ready to split into two separate companies next year
Johnson & Johnson (JNJ) is preparing next year to spin off its consumer health unit into a publicly traded company separate from its pharmaceutical and medical technology operations. Ahead of the split, Morgan Stanley put out a research note, highlighting some of the debates in the market over the move, which would result in a […]
Read More
Stability in a risky current market? Within an S&P 500 ETF offering double-digit share dividends
ETF Edge Stability in a risky marketplace? Inside an S&P 500 ETF providing double-digit share dividends Revealed Sat, Nov 5 202211:00 AM EDT Noah Sheidlower@NSheidlower Enjoy Live Resource
Read More
The market place could be anticipating a Republican sweep of Congress in Tuesday’s election
Stocks that would profit from Republican guidelines have been relocating larger, signaling that traders anticipate the GOP might have much better odds of using the two homes of Congress. Dan Clifton, head of policy investigate at Strategas, built Republican and Democratic portfolios, which contain investments that would have the most to acquire or lose based […]
Read More
Stocks could keep on to break better as Apple, huge tech report earnings in 7 days in advance
Stocks are predicted to just take their cue from the bond industry in the week forward, as traders weigh earnings from bellwethers Apple, Microsoft, and Alphabet. Strategists proceed to look at the market’s investing styles for signs a bottom is forming right after the Oct. 13 washout, when the marketplace initially fell and then surged […]
Read More
Jim Cramer makes the bull case for consumer goods stocks
CNBC’s Jim Cramer on Wednesday told investors to consider adding shares of well-established consumer packaged-goods companies to their portfolios. “Nobody’s championing what actually works: these old-line consumer packaged-goods names that we all know,” he said. Cramer highlighted three companies’ most recent quarterly results as examples of why investors should have such stocks on their shopping […]
Read More
A series of mega-blockbuster drugs are on the horizon. How to invest in the trend
Biopharma companies are having more clinical success treating Alzheimer’s disease and obesity and are taking new approaches in oncology, and that’s creating more mega-blockbuster drugs, according to Bank of America. Analyst Geoff Meacham has identified 20 drugs that have the potential to generate $10 billion or more in annual sales by 2030 within the universe […]
Read More